ORAGENICS, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $939.9K | $1.0M | $1.3M | $1.4M |
| Cost of Revenue | — | $0 | $0 | $0 | $369.6K | $343.4K | $878.5K | $713.6K |
| Gross Profit | — | $0 | $0 | $0 | $570.3K | $688.9K | $453.3K | $730.8K |
| Gross Margin | — | — | — | — | 60.7% | 66.7% | 34.0% | 50.6% |
| Operating Expenses | ||||||||
| Research & Development | $6.0M | $3.5M | $4.8M | $8.7M | $3.1M | $9.4M | $7.9M | $2.4M |
| SG&A Expense | $4.0M | $3.2M | $3.8M | $3.5M | $3.3M | $7.5M | $5.0M | $5.6M |
| Operating Income | $-10.0M | $-6.7M | $-8.5M | $-11.8M | $-5.8M | $-16.2M | $-12.4M | $-7.3M |
| Operating Margin | — | — | — | — | -618.8% | -1,570.4% | -933.5% | -508.6% |
| Interest Expense | $5.8K | $216.3K | $4.1K | $76.7K | $4.0K | $17.5K | $655.6K | $332.3K |
| Pretax Income | $-9.9M | $-6.7M | $-8.5M | $-11.8M | $-5.8M | $-16.1M | $-13.1M | $-7.7M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Net Income | $-9.9M | $-6.7M | $-7.0M | $-11.7M | $-5.8M | $-16.1M | $-13.1M | $-7.7M |
| Net Margin | — | — | — | — | -616.0% | -1,556.7% | -982.9% | -531.6% |
| EPS (Basic) | $-0.09 | $-0.14 | $-0.16 | $-0.03 | $-0.02 | $-0.06 | $-0.07 | $-0.13 |
| EPS (Diluted) | $-0.09 | $-0.14 | $-0.16 | $-0.03 | $-0.02 | $-0.06 | $-0.07 | $-0.13 |
| Shares Outstanding (Basic) | 294.3M | 49.3M | 49.1M | 398.6M | 361.8M | 359.9M | 273.8M | 58.9M |
| Shares Outstanding (Diluted) | 294.3M | 49.3M | 49.1M | 398.6M | 361.8M | 359.9M | 273.8M | 58.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |